Grepafloxacin

Grepafloxacin

File:Grepafloxacin.svg
Clinical data
ATC code	J01MA11 (WHO)
Pharmacokinetic data
Protein binding	50%
Identifiers
IUPAC name 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline- 3-carboxylic acid
CAS Number	119914-60-2
PubChem CID	72474
DrugBank	APRD01003
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C19H22FN3O3
Molar mass	359.395 g/mol

WikiDoc Resources for Grepafloxacin
Articles
Most recent articles on Grepafloxacin Most cited articles on Grepafloxacin Review articles on Grepafloxacin Articles on Grepafloxacin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Grepafloxacin Images of Grepafloxacin Photos of Grepafloxacin Podcasts & MP3s on Grepafloxacin Videos on Grepafloxacin
Evidence Based Medicine
Cochrane Collaboration on Grepafloxacin Bandolier on Grepafloxacin TRIP on Grepafloxacin
Clinical Trials
Ongoing Trials on Grepafloxacin at Clinical Trials.gov Trial results on Grepafloxacin Clinical Trials on Grepafloxacin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Grepafloxacin NICE Guidance on Grepafloxacin NHS PRODIGY Guidance FDA on Grepafloxacin CDC on Grepafloxacin
Books
Books on Grepafloxacin
News
Grepafloxacin in the news Be alerted to news on Grepafloxacin News trends on Grepafloxacin
Commentary
Blogs on Grepafloxacin
Definitions
Definitions of Grepafloxacin
Patient Resources / Community
Patient resources on Grepafloxacin Discussion groups on Grepafloxacin Patient Handouts on Grepafloxacin Directions to Hospitals Treating Grepafloxacin Risk calculators and risk factors for Grepafloxacin
Healthcare Provider Resources
Symptoms of Grepafloxacin Causes & Risk Factors for Grepafloxacin Diagnostic studies for Grepafloxacin Treatment of Grepafloxacin
Continuing Medical Education (CME)
CME Programs on Grepafloxacin
International
Grepafloxacin en Espanol Grepafloxacin en Francais
Business
Grepafloxacin in the Marketplace Patents on Grepafloxacin
Experimental / Informatics
List of terms related to Grepafloxacin

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Grepafloxacin hydrochloride (Raxar®, Glaxo Wellcome) is an oral broad-spectrum quinoline antibacterial agent used to treat bacterial infections. Grepafloxacin was withdrawn in the United States due to its side effect of lengthening the QT interval on the electrocardiogram, leading to cardiac events and sudden death.

Template:SIB